• Je něco špatně v tomto záznamu ?

Lesion durability found during mandated percutaneous catheter ablation after surgical cryo-ablation for treatment of non-paroxysmal atrial fibrillation

A. Bulava, A. Mokráček, P. Němec, D. Wichterle, P. Osmančík, P. Budera, P. Kačer, L. Vetešková, T. Skála, P. Šantavý, J. Chovančík, P. Branny, V. Rizov, M. Kolesár, I. Šafaříková, M. Rybář, SURHYB Trial Investigators

. 2024 ; 19 (1) : 397. [pub] 20240627

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013439

Grantová podpora
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic
NV19-02-00046 Ministry of Health of the Czech Republic

OBJECTIVES: Current recommendations support surgical treatment of atrial fibrillation (AF) in patients indicated for cardiac surgery. These procedures are referred to as concomitant and may be carried out using radiofrequency energy or cryo-ablation. This study aimed to assess the electrophysiological findings in patients undergoing concomitant cryo-ablation. METHODS: Patients with non-paroxysmal AF undergoing coronary artery bypass grafting and/or valve repair/replacement were included in the trial if concomitant cryo-ablation was part of the treatment plan according to current guidelines. The patients reported in this study were assigned to undergo staged percutaneous radiofrequency catheter ablation (PRFCA), i.e., hybrid treatment, as a part of the SURHYB trial protocol. RESULTS: We analyzed 103 patients who underwent PRFCA 105 ± 35 days after surgery. Left and right pulmonary veins (PVs) were found isolated in 65 (63.1%) and 63 (61.2%) patients, respectively. The LA posterior wall isolation and mitral isthmus conduction block were found in 38 (36.9%) and 18 (20.0%) patients, respectively. Electrical reconnections (gaps) in the left PVs were more often localized superiorly than inferiorly (57.9% vs. 26.3%, P = 0.005) and anteriorly than posteriorly (65.8% vs. 31.6%, P = 0.003). Gaps in the right PVs were more equally distributed anteroposteriorly but dominated in superior segments (72.5% vs. 40.0%, P = 0.003). There was a higher number of gaps on the roof line compared to the inferior line (131 (67.2%) vs. 67 (42.2%), P < 0.001). Compared to epicardial cryo-ablation, endocardial was more effective in creating PVs and LA posterior wall isolation (P < 0.05). Cryo-ablation using nitrous oxide (N20) or argon (Ar) gas as cooling agents was similarly effective (P = NS). CONCLUSIONS: The effectiveness of surgical cryo-ablation in achieving transmural and durable lesions in the left atrium is surprisingly low. Gaps are located predominantly in the superior and anterior portions of the PVs and on the roof line. Endocardial cryo-ablation is more effective than epicardial ablation, irrespective of the cooling agent used.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013439
003      
CZ-PrNML
005      
20240905134059.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13019-024-02889-3 $2 doi
035    __
$a (PubMed)38937763
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bulava, Alan $u Faculty of Health and Social Sciences, University of South Bohemia in České Budějovice and Cardiac Centre, České Budějovice Hospital, České Budějovice, Czechia. alanbulava@seznam.cz
245    10
$a Lesion durability found during mandated percutaneous catheter ablation after surgical cryo-ablation for treatment of non-paroxysmal atrial fibrillation / $c A. Bulava, A. Mokráček, P. Němec, D. Wichterle, P. Osmančík, P. Budera, P. Kačer, L. Vetešková, T. Skála, P. Šantavý, J. Chovančík, P. Branny, V. Rizov, M. Kolesár, I. Šafaříková, M. Rybář, SURHYB Trial Investigators
520    9_
$a OBJECTIVES: Current recommendations support surgical treatment of atrial fibrillation (AF) in patients indicated for cardiac surgery. These procedures are referred to as concomitant and may be carried out using radiofrequency energy or cryo-ablation. This study aimed to assess the electrophysiological findings in patients undergoing concomitant cryo-ablation. METHODS: Patients with non-paroxysmal AF undergoing coronary artery bypass grafting and/or valve repair/replacement were included in the trial if concomitant cryo-ablation was part of the treatment plan according to current guidelines. The patients reported in this study were assigned to undergo staged percutaneous radiofrequency catheter ablation (PRFCA), i.e., hybrid treatment, as a part of the SURHYB trial protocol. RESULTS: We analyzed 103 patients who underwent PRFCA 105 ± 35 days after surgery. Left and right pulmonary veins (PVs) were found isolated in 65 (63.1%) and 63 (61.2%) patients, respectively. The LA posterior wall isolation and mitral isthmus conduction block were found in 38 (36.9%) and 18 (20.0%) patients, respectively. Electrical reconnections (gaps) in the left PVs were more often localized superiorly than inferiorly (57.9% vs. 26.3%, P = 0.005) and anteriorly than posteriorly (65.8% vs. 31.6%, P = 0.003). Gaps in the right PVs were more equally distributed anteroposteriorly but dominated in superior segments (72.5% vs. 40.0%, P = 0.003). There was a higher number of gaps on the roof line compared to the inferior line (131 (67.2%) vs. 67 (42.2%), P < 0.001). Compared to epicardial cryo-ablation, endocardial was more effective in creating PVs and LA posterior wall isolation (P < 0.05). Cryo-ablation using nitrous oxide (N20) or argon (Ar) gas as cooling agents was similarly effective (P = NS). CONCLUSIONS: The effectiveness of surgical cryo-ablation in achieving transmural and durable lesions in the left atrium is surprisingly low. Gaps are located predominantly in the superior and anterior portions of the PVs and on the roof line. Endocardial cryo-ablation is more effective than epicardial ablation, irrespective of the cooling agent used.
650    _2
$a lidé $7 D006801
650    12
$a fibrilace síní $x chirurgie $7 D001281
650    12
$a kryochirurgie $x metody $7 D003452
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a katetrizační ablace $x metody $7 D017115
650    _2
$a lidé středního věku $7 D008875
650    _2
$a senioři $7 D000368
650    12
$a venae pulmonales $x chirurgie $7 D011667
650    _2
$a výsledek terapie $7 D016896
650    _2
$a koronární bypass $x metody $7 D001026
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mokráček, Aleš $u Faculty of Health and Social Sciences, University of South Bohemia in České Budějovice and Cardiac Centre, České Budějovice Hospital, České Budějovice, Czechia
700    1_
$a Němec, Petr $u Centre of Cardiovascular Surgery and Transplantation and Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Wichterle, Dan $u Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Osmančík, Pavel $u 3rd Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czechia
700    1_
$a Budera, Petr $u Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Kačer, Petr $u 3rd Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czechia
700    1_
$a Vetešková, Linda $u Centre of Cardiovascular Surgery and Transplantation and Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Skála, Tomáš $u Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc, Czechia
700    1_
$a Šantavý, Petr $u Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc, Czechia
700    1_
$a Chovančík, Jan $u Hospital Agel Třinec - Podlesí, Třinec, Czechia
700    1_
$a Branny, Piotr $u Hospital Agel Třinec - Podlesí, Třinec, Czechia
700    1_
$a Rizov, Vitalii $u Masaryk Hospital, Ústí Nad Labem, Czechia
700    1_
$a Kolesár, Miroslav $u Masaryk Hospital, Ústí Nad Labem, Czechia
700    1_
$a Šafaříková, Iva $u Faculty of Health and Social Sciences, University of South Bohemia in České Budějovice and Cardiac Centre, České Budějovice Hospital, České Budějovice, Czechia
700    1_
$a Rybář, Marian $u Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czechia
710    2_
$a SURHYB Trial Investigators
773    0_
$w MED00163181 $t Journal of cardiothoracic surgery $x 1749-8090 $g Roč. 19, č. 1 (2024), s. 397
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38937763 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134053 $b ABA008
999    __
$a ok $b bmc $g 2143329 $s 1225305
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 19 $c 1 $d 397 $e 20240627 $i 1749-8090 $m Journal of cardiothoracic surgery $n J Cardiothorac Surg $x MED00163181
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
GRA    __
$a NV19-02-00046 $p Ministry of Health of the Czech Republic
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...